EN
Patient-first cell therapy innovation
Pipelines
China Global U.S.A
ASPIRE/ARMORS-T
Product
Technology
Indication
Pre-clinical
Phase I/Clinical trials
Phase II/III*
NDA/BLA
A100S
ASPIRE
Ovarian, Cervical, Endometrial and Lung cancer, Testicular tumor, and other solid tumors
 
I301
ASPIRE ARMORS
Glioma
 
L200s
TRUST ARMORS
NPC and NKT lymphoma
 
N201
TRUST ARMORS
synovial sarcoma, lung cancer, and other solid tumors
 
H101
Tumor vaccine
DIPG
 
G201
ASPIRE ARMORS
Liver cancer, Digestive system tumor, and other solid tumors
 
D201
ASPIRE ARMORS
Small cell lung cancer, Neuroendocrine tumors
 
K201
TRUST ARMORS
Lung, Bowel, Pancreatic cancer, and other solid tumors
 
HBV100S
ASPIRE
Liver cancer
 

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer